Paul Brunetta - Concepedia

Author

Paul Brunetta

Also Known As

Brunetta, Paul, P Brunetta, P G Brunetta, P.G. Brunetta, PAUL BRUNETTA, Paul Brunetta, Paul G Brunetta, Paul G. Brunetta

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Mayo Clinic Massachusetts General Hospital Cleveland Clinic Hospital for Special Surgery

About

Paul Brunetta is an author at Johns Hopkins University specializing in medicine, immunology, and lupus.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	183
2	Public Health	2	2	144
3	Health Sciences	1	1	17
4	Social Sciences	1	1	10
5	Cell Biology	1	1	17

Paul Brunetta

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis John H. Stone, Peter A. Merkel, Robert Spiera, New England Journal of Medicine	2010	2.7K
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study Brad H. Rovin, Richard Furie, Kevin Latinis, Arthritis & Rheumatism	2012	1.4K
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace, Arthritis & Rheumatism	2009	1.3K
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis Ulrich Specks, Peter A. Merkel, Philip Seo, New England Journal of Medicine	2013	713
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial Richard Furie, Gustavo Aroca, Matthew D. Cascino, Annals of the Rheumatic Diseases	2022	392
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study Eduardo Mysler, Alberto Spindler, Renato Guzmán, Arthritis & Rheumatism	2013	345
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type Sebastian Unizony, Miguel Villarreal, Eli M. Miloslavsky, Annals of the Rheumatic Diseases	2015	258
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis Eli M. Miloslavsky, Ray Naden, J. W. J. Bijlsma, Annals of the Rheumatic Diseases	2016	220
International consensus for a definition of disease flare in lupus Nicolino Ruperto, LM Hanrahan, Alarcón Gs, Lupus	2010	182
Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement Duvuru Geetha, Ulrich Specks, John H. Stone, Journal of the American Society of Nephrology	2014	174

Page 1